JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 3, Pages 736-743
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1038/leu.2017.287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple myeloma in the marrow: pathogenesis and treatments
- (2016) Heather Fairfield et al. Annals of the New York Academy of Sciences
- Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance
- (2016) B. Paiva et al. BLOOD
- Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells –Implications for myeloma bone disease
- (2016) Julia Dotterweich et al. BONE
- Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma
- (2016) Yusuke Furukawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF
- (2016) David W. Scott et al. MOLECULAR BIOLOGY OF THE CELL
- The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease
- (2016) Julia Dotterweich et al. PLoS One
- Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4
- (2016) Chao-Hui Chang et al. STEM CELLS
- Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma
- (2016) Takuya Kakuki et al. Oncotarget
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
- (2015) K. Philipp-Abbrederis et al. EMBO Molecular Medicine
- Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
- (2015) Kevin R. Kelly et al. Oncotarget
- Junctional adhesion molecule-A, an epithelial–mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer
- (2014) Yunhong Tian et al. CARCINOGENESIS
- Jam1a–Jam2a interactions regulate haematopoietic stem cell fate through Notch signalling
- (2014) Isao Kobayashi et al. NATURE
- High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor
- (2014) Justin D. Lathia et al. Cell Reports
- Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging
- (2013) Andreas Thalheimer et al. JOURNAL OF SURGICAL RESEARCH
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
- (2013) Joseph R. Mikhael et al. MAYO CLINIC PROCEEDINGS
- Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression
- (2013) Min Zhang et al. PLoS One
- Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line
- (2012) Pelin Mutlu et al. BIOMEDICINE & PHARMACOTHERAPY
- A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody
- (2012) Liliane Goetsch et al. INTERNATIONAL JOURNAL OF CANCER
- Mapping immune processes in intact tissues at cellular resolution
- (2012) Christian Brede et al. JOURNAL OF CLINICAL INVESTIGATION
- Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
- (2012) A Ikegame et al. LEUKEMIA
- Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma
- (2012) H Tamura et al. LEUKEMIA
- Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma
- (2012) Simone S. Riedel et al. PLoS One
- Integrin 7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
- (2011) P. Neri et al. BLOOD
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
- (2011) M. Cavo et al. BLOOD
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Elevated Plasma Level of Soluble F11 Receptor/Junctional Adhesion Molecule-A (F11R/JAM-A) in Hypertension
- (2009) K. L. Ong et al. AMERICAN JOURNAL OF HYPERTENSION
- Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases
- (2009) Rory R. Koenen et al. BLOOD
- Junctional Adhesion Molecule A Interacts with Afadin and PDZ-GEF2 to Activate Rap1A, Regulate β1 Integrin Levels, and Enhance Cell Migration
- (2009) Eric A. Severson et al. MOLECULAR BIOLOGY OF THE CELL
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started